A ROS-Scavenging and Conductive Hydrogel-Based Cardiac Patch with Controlled Release of Edaravone for Myocardial...

Area of Science:

• Biomaterials Science
• Cardiovascular Research
• Regenerative Medicine

Background:

• Myocardial infarction (MI) is a leading cause of global mortality, characterized by disrupted electrical conduction, cardiomyocyte damage, and excessive reactive oxygen species (ROS) production.
• Addressing the dual challenges of restoring electrical integrity and mitigating oxidative stress is crucial for effective MI treatment.

Purpose of the Study:

• To design and synthesize a novel hydrogel with enhanced properties for treating myocardial infarction.
• To evaluate the hydrogel's efficacy in improving the cardiac microenvironment and electrical signal transmission in vivo.

Main Methods:

• Synthesis of an MPSHU@EDR hydrogel with specific mechanical, electrical, and antioxidant properties.
• In vivo studies to assess the hydrogel's impact on the ROS microenvironment and electrical conduction in a myocardial infarction model.

Main Results:

• The MPSHU@EDR hydrogel demonstrated excellent mechanical properties, electrical conductivity, ROS-scavenging, and antioxidant activity.
• In vivo studies confirmed the hydrogel's ability to improve the ROS microenvironment and enhance electrical signal transmission post-MI.

Conclusions:

• The developed MPSHU@EDR hydrogel shows significant potential as an optimal therapeutic candidate for myocardial infarction treatment.
• The hydrogel's combined ROS-scavenging and electrical conductivity properties address key pathological features of MI.